Dr. med. Gerald Wulf

Name Card

Main Affiliation
 
Staff Status
unigoe
 

1-15 of 15
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2022 | Journal Article | Research Paper | 
    ​ ​“SpezPat”- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians’ understanding of non-small cell lung cancer patients’ end-of-life decisions​
    Koenig, J. F. L.; Asendorf, T. ; Simon, A. ; Bleckmann, A. ; Trümper, L. ; Wulf, G. G.   & Overbeck, T. R. ​ (2022) 
    BMC Palliative Care, 21(1) art. 167​.​ DOI: https://doi.org/10.1186/s12904-022-01057-5 
    ​Details  DOI 
  • 2022 | Journal Article | Research Paper | 
    ​ ​Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis​
    Shumilov, E.; Aperdannier, L.; Schmidt, N.; Szuszies, C.; Neesse, A. ; Hoffknecht, P. & Khandanpour, C. et al.​ (2022) 
    Cancers, 14(15).​ DOI: https://doi.org/10.3390/cancers14153746 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients​
    Ziepert, M.; Lazzi, S.; Santi, R.; Vergoni, F.; Granai, M.; Mancini, V. & Staiger, A. et al.​ (2020) 
    Haematologica, 105(11) pp. 2667​-2670​.​ DOI: https://doi.org/10.3324/haematol.2019.235556 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial​
    Wulf, G. G. ; Altmann, B.; Ziepert, M.; D’Amore, F.; Held, G.; Greil, R. & Tournilhac, O. et al.​ (2020) 
    Leukemia,.​ DOI: https://doi.org/10.1038/s41375-020-0838-5 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Am individuellen Therapieergebnis orientierte Erstattungsverfahren in der Onkologie: ethische Implikationen am Beispiel der CAR-T-Zelltherapie​
    König, J.; Gerst, C.; Trümper, L. ; Wulf, G. G.   & Wiesemann, C. ​ (2020) 
    Ethik in der Medizin, 32(1) pp. 85​-92​.​ DOI: https://doi.org/10.1007/s00481-020-00565-3 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation​
    Bleckmann, A. ; Dierks, S.; Schildhaus, H.-U. ; Hellige, N.; Bacher, U. ; Trümper, L.   & Wulf, G. ​ (2020) 
    Annals of Hematology,.​ DOI: https://doi.org/10.1007/s00277-020-03974-y 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)​
    Zettl, F.; Ziepert, M.; Altmann, B.; Zeynalova, S.; Held, G.; Pöschel, V. & Hohloch, K.  et al.​ (2020) 
    Annals of Hematology, 100(4) pp. 1031​-1038​.​ DOI: https://doi.org/10.1007/s00277-020-04345-3 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant​
    d'Amore, F.; Leppä, S.; Silva, M. G. da; Relander, T.; Lauritzsen, G. F.; Brown, P. D. N. & Pezzutto, A. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 998​-998​.​ DOI: https://doi.org/10.1182/blood-2018-99-110429 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease​
    Wulf, G. ; Hasenkamp, J. ; Jung, W. ; Wilhelm, C.; Held, G.; Nickelsen, M. & Leha, A.  et al.​ (2018) 
    Bone Marrow Transplantation, 54(6) pp. 877​-884​.​ DOI: https://doi.org/10.1038/s41409-018-0360-9 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas​
    Venkataramani, V. ; Küffer, S. ; Cheung, K. C.; Jiang, X.; Trümper, L. ; Wulf, G. G.   & Ströbel, P. ​ (2018) 
    Clinical Cancer Research, 24(2) pp. 460​-473​.​ DOI: https://doi.org/10.1158/1078-0432.CCR-17-1778 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens​
    Oyekunle, A.; Shumilov, E.; Kostrewa, P.; Burchert, A.; Trümper, L. ; Wuchter, P. & Wulf, G.  et al.​ (2018) 
    Biology of Blood and Marrow Transplantation, 24(2) pp. 276​-281​.​ DOI: https://doi.org/10.1016/j.bbmt.2017.10.008 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​In Situ Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis​
    Shumilov, E.; Bacher, U. ; Perske, C. ; Mohr, A. ; Eiffert, H. ; Hasenkamp, J.   & Trümper, L.  et al.​ (2018) 
    Antimicrobial Agents and Chemotherapy, 62(5).​ DOI: https://doi.org/10.1128/AAC.00172-18 
    ​Details  DOI 
  • 2018 | Journal Article | Research Paper
    ​ ​Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes​
    Chapuy, B. ; Stewart, C.; Dunford, A. J.; Kim, J.; Kamburov, A.; Redd, R. A. & Lawrence, M. S. et al.​ (2018) 
    Nature Medicine, 24(5) pp. 679​-690​.​ DOI: https://doi.org/10.1038/s41591-018-0016-8 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib​
    Shumilov, E.; Wulf, G. ; Ströbel, P. ; Hasenkamp, J. ; Hellige, N.; Bleckmann, A.   & Haase, D.  et al.​ (2016) 
    Leukemia & Lymphoma, 57(10) pp. 2476​-2480​.​ DOI: https://doi.org/10.3109/10428194.2016.1151510 
    ​Details  DOI 
  • 2009 | Journal Article | Research Paper
    ​ ​Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3​
    Piesche, M.; Hildebrandt, Y.; Chapuy, B. ; Wulf, G. G. ; Truemper, L. H.   & Schroers, R.​ (2009) 
    Vaccine, 27(34) pp. 4718​-4723​.​ DOI: https://doi.org/10.1016/j.vaccine.2009.05.010 
    ​Details  DOI  PMID  PMC  WoS 

Publication List

All Articles (Book & Journal) Articles & Preprints Papers (Journal & Conference)

Filter

Active filter:
Contributor:  Trümper, Lorenz

Type

Subtype

Date issued

Author

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp34512
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.